Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Connective tissue diseases

What does the death of Riquent™ hold for the future of SLE?

Nature Reviews Rheumatology volume 5, pages 306–307 (2009)Cite this article

In clinical trials testing new treatments for systemic lupus erythematosus (SLE), the failure of the 15-year drug development program for Riquent™ (abetimus sodium) is the latest in a string of disappointments for a disease that has seen no new drugs approved in over 50 years.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Dey, E. UPDATE 2—La Jolla stops developing lupus drug; shares tank. http://www.reuters.com/article/marketsNews/idUSBNG16819820090212 (2009).

    Google Scholar 

  2. Study of LJP 394 in lupus patients with history of renal disease (ASPEN). http://www.clinicaltrials.gov/ct2/show/NCT00089804 (2009).

  3. Furie, R. A. et al. Treatment of systemic lupus erythematosus with LJP 394. J. Rheumatol. 28, 257–265 (2001).

    CAS  PubMed  Google Scholar 

  4. Alarcón-Segovia, D. et al. LJP 394 for the prevention of renal flare in patients with systemic lupus erythematosus: results from a randomized, double-blind, placebo-controlled study. Arthritis Rheum. 48, 442–454 (2003).

    Article  Google Scholar 

  5. Cardiel, M. H. et al. Abetimus sodium for renal flare in systemic lupus erythematosus: results of a randomized, controlled phase III trial. Arthritis Rheum. 58, 2470–2480 (2008).

    Article  CAS  Google Scholar 

  6. Alarcón, G. S. et al. Baseline characteristics of a multiethnic lupus cohort: PROFILE. Lupus 11, 95–101 (2002).

    Article  Google Scholar 

  7. Dooley, M. A. & Ginzler, E. M. Newer therapeutic approaches for systemic lupus erythematosus: immunosuppressive agents. Rheum. Dis. Clin. North Am. 32, 91–102 (2006).

    Article  Google Scholar 

  8. Linnik, M. D., O'Rourke, A. M. & Crowther, M. A. Pharmacokinetics of high-dose abetimus sodium in normal subjects with specific assessment of effect on coagulation. J. Clin. Pharmacol. 48, 909–918 (2008).

    Article  CAS  Google Scholar 

  9. Buyon, J. P. Neonatal lupus syndromes. Am. J. Reprod. Immunol. 28, 259–263 (1992).

    Article  CAS  Google Scholar 

  10. López, P., Gómez, J., Prado, C., Gutiérrez, C. & Suárez, A. Influence of functional interleukin 10/tumor necrosis factor-α polymorphisms on interferon-α, IL-10, and regulatory T cell population in patients with systemic lupus erythematosus receiving antimalarial treatment. J. Rheumatol. 35, 1559–1566 (2008).

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Oklahoma Medical Research Foundation, Oklahoma City, OK, USA

    Joan T. Merrill

  2. New York University School of Medicine, New York, NY, USA

    Jill P. Buyon

Authors
  1. Joan T. Merrill
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jill P. Buyon
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Joan T. Merrill.

Ethics declarations

Competing interests

The authors have acted as consultants for and received grant/research support from La Jolla Pharmaceutical Company.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Merrill, J., Buyon, J. What does the death of Riquent™ hold for the future of SLE?. Nat Rev Rheumatol 5, 306–307 (2009). https://doi.org/10.1038/nrrheum.2009.99

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrrheum.2009.99

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing